Skip to main content

Table 3 Kaplan–Meier analysis of prognostic factors of 90-day survival in 61 patients with chronic disseminated candidiasis

From: Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies

 

Total

(n = 61)

Alive

(n = 49)

Death

(n = 12)

Univariate

p

Multivariate

p

Age

   

0.539

 

 Age > =65 years

9

8

1

  

 Age < 65 years

52

41

11

  

Gender

   

0.427

 

 Men

32

27

5

  

 Women

29

22

7

  

Hematological subtype

   

< 0.001

0.225

 AML

38

34

4

  

 ALL

13

8

5

  

 Lymphoma

7

5

2

  

 CML/MPN

1

1

0

  

 CLL

0

0

0

  

 Myeloma

1

1

0

  

 MDS/SAA

1

0

1

  

Preceding allogeneic transplantation

   

< 0.001

0.128

 Yes

5

1

4

  

 No

56

48

8

  

Neutropenia<=500 / mm3

   

0.650

 

 Yes

19

16

3

  

 No

42

33

9

  

Thrombocytopenia

   

0.905

 

 Platelet > = 20000 / mm3

52

42

10

  

 Platelet < 20000 / mm3

9

7

2

  

Proven or Probable CDC

   

0.492

 

 Yes

16

12

4

  

 No

45

37

8

  

Initial anti-fungal agent

   

< 0.001

0.624

 Amphotericin B

9

7

2

  

 Fluconazole

35

29

6

  

 Itraconazole

1

0

1

  

 Voriconazole

6

6

0

  

 Posaconazole

2

1

1

  

 Caspofungin

1

0

1

  

 Micafungin

3

3

0

  

 Anidulafungin

2

1

1

  

 none

2

2

0

  

Hepatitis B carrier

   

0.186

 

 Yes

7

7

0

  

 No

54

42

12

  

Diabetes mellitus

   

0.854

 

 Yes

9

7

2

  

 No

52

42

10

  

Shock

   

< 0.001

0.016

 Yes

8

0

8

  

 No

53

49

4

  
  1. Abbreviations: AML acute myeloid leukemia, ALL acute lymphoblastic leukemia, CML chronic myeloid leukemia, MPN myeloid proliferative neoplasm, CLL chronic lymphoid leukemia, MDS myelodysplastic syndrome, SAA severe aplastic anemia, CDC chronic disseminated candidiasis